Ajit Lalvani1, Kerry A Millington. 1. Tuberculosis Immunology Group, Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom. a.lalvani@imperial.ac.uk
Authors: Victoria O Kasprowicz; Gavin Churchyard; Stephen D Lawn; S Bertel Squire; Ajit Lalvani Journal: J Infect Dis Date: 2011-11-15 Impact factor: 5.226
Authors: Jayne S Sutherland; Bouke C de Jong; David J Jeffries; Ifedayo M Adetifa; Martin O C Ota Journal: PLoS One Date: 2010-08-24 Impact factor: 3.240
Authors: Katrina M Pollock; Damien J Montamat-Sicotte; Graham S Cooke; Moses S Kapembwa; Onn M Kon; Lisa Grass; Robert D Sampson; Graham P Taylor; Ajit Lalvani Journal: Immun Inflamm Dis Date: 2015-04-29
Authors: Gillian F Black; Bonnie A Thiel; Martin O Ota; Shreemanta K Parida; Richard Adegbola; W Henry Boom; Hazel M Dockrell; Kees L M C Franken; Annemiek H Friggen; Philip C Hill; Michel R Klein; Maeve K Lalor; Harriet Mayanja; Gary Schoolnik; Kim Stanley; Karin Weldingh; Stefan H E Kaufmann; Gerhard Walzl; Tom H M Ottenhoff Journal: Clin Vaccine Immunol Date: 2009-06-24
Authors: Elihu Aranday-Cortes; Philip J Hogarth; Daryan A Kaveh; Adam O Whelan; Bernardo Villarreal-Ramos; Ajit Lalvani; H Martin Vordermeier Journal: PLoS One Date: 2012-02-16 Impact factor: 3.240